Patents by Inventor Michael D. Carter

Michael D. Carter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for identifying inhibitors of amyloid protein aggregation
    Patent number: 11568956
    Abstract: Methods for identifying compounds that are inhibitors or are likely to be inhibitors of amyloid protein aggregation, as well as three-dimensional, non-crystallographic models (i.e. “pseudo-crystal structures”) of amyloid aggregation utilized in the methods, are described. Means for creating the three-dimensional, non-crystallographic models (i.e. “pseudo-crystal structures”) of amyloid aggregation are also described.
    Type: Grant
    Filed: October 26, 2018
    Date of Patent: January 31, 2023
    Assignee: Treventis Corporation
    Inventors: Christopher J. Barden, Michael D. Carter, Donald F. Weaver
  • METHODS FOR IDENTIFYING INHIBITORS OF AMYLOID PROTEIN AGGREGATION
    Publication number: 20190050526
    Abstract: Methods for identifying compounds that are inhibitors or are likely to be inhibitors of amyloid protein aggregation, as well as three-dimensional, non-crystallographic models (i.e. “pseudo-crystal structures”) of amyloid aggregation utilized in the methods, are described. Means for creating the three-dimensional, non-crystallographic models (i.e. “pseudo-crystal structures”) of amyloid aggregation are also described.
    Type: Application
    Filed: October 26, 2018
    Publication date: February 14, 2019
    Applicant: Treventis Corporation
    Inventors: Christopher J. Barden, Michael D. Carter, Donald F. Weaver
  • METHODS FOR IDENTIFYING INHIBITORS OF AMYLOID PROTEIN AGGREGATION
    Publication number: 20160283652
    Abstract: Methods for identifying compounds that are inhibitors or are likely to be inhibitors of amyloid protein aggregation, as well as three-dimensional, non-crystallographic models (i.e. “pseudo-crystal structures”) of amyloid aggregation utilized in the methods, are described. Means for creating the three-dimensional, non-crystallographic models (i.e. “pseudo-crystal structures”) of amyloid aggregation are also described.
    Type: Application
    Filed: May 16, 2016
    Publication date: September 29, 2016
    Applicant: Treventis Corporation
    Inventors: Christopher J. BARDEN, Michael D. Carter, Donald F. Weaver
  • Methods of treating amyloid disease using analogs of 1-(4-nitrophenyl) piperazine
    Patent number: 8420640
    Abstract: The present invention is directed to compounds that inhibit amyloid aggregation and methods of treatment therewith.
    Type: Grant
    Filed: August 28, 2009
    Date of Patent: April 16, 2013
    Assignee: Treventis Corporation
    Inventors: Christopher J. Barden, Michael D. Carter, Mark A. Reed, Donald F. Weaver, Arun Yadav, Shengguo Sun
  • Compounds and methods for treating protein folding disorders
    Patent number: 8362066
    Abstract: The invention is directed to compounds and methods for treating protein folder disorders. In certain embodiments the invention provides compounds and methods for treating neurodegenerative diseases such as Alzheimer's disease, tauopathy, cerebral amyloid angiopathy, Lewy body disease, dementia, Huntington's disease and prion-based spongiform encelopathy. The invention further provides compounds, methods and pharmaceutical compositions for inhibiting tau protein, A? protein or ?-synuclein protein aggregation.
    Type: Grant
    Filed: November 19, 2007
    Date of Patent: January 29, 2013
    Assignee: Treventis Corporation
    Inventors: Michael D. Carter, Donald F. Weaver, Sheila Marie H. Jacobo, Erhu Lu, Fuye Gao
  • METHODS OF TREATING AMYLOID DISEASE USING ANALOGS OF 1-(4-NITROPHENYL) PIPERAZINE
    Publication number: 20110218200
    Abstract: The present invention is directed to compounds that inhibit amyloid aggregation and methods of treatment there-with.
    Type: Application
    Filed: August 28, 2009
    Publication date: September 8, 2011
    Inventors: Christopher J. Barden, Michael D. Carter, Mark A. Reed, Donald F. Weaver, Arun Yadav, Shengguo Sun
  • COMPOUNDS AND METHODS FOR TREATING PROTEIN FOLDING DISORDERS
    Publication number: 20100144821
    Abstract: The invention is directed to compounds and methods for treating protein folder disorders. In certain embodiments the invention provides compounds and methods for treating neurodegenerative diseases such as Alzheimer's disease, tauopathy, cerebral amyloid angiopathy, Lewy body disease, dementia, Huntington's disease and prion-based spongiform encelopathy. The invention further provides compounds, methods and pharmaceutical compositions for inhibiting tau protein, A? protein or ?-synuclein protein aggregation.
    Type: Application
    Filed: November 19, 2007
    Publication date: June 10, 2010
    Applicant: Queen's University at Kingston
    Inventors: Michael D. Carter, Donald F. Weaver, Sheila Marie H. Jacobo, Erhu Lu, Fuye Gao
  • Patient leg support
    Patent number: D359804
    Type: Grant
    Filed: February 28, 1994
    Date of Patent: June 27, 1995
    Inventor: Michael D. Carter